CIAM
SNTI icon

Caitong International Asset Management’s Senti Biosciences Holdings SNTI Stock Holding History

Caitong International Asset Management’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1 Hold
1
– – ﹤0.01% 2915
2026
Q1 		$1 Buy
+1
New +$1 ﹤0.01% 2515

Other funds holding SNTI

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
MVM
Menlo Ventures Management Menlo Park, California $357M AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Caitong International Asset Management's SNTI Position: Q2 2026 in Review

Caitong International Asset Management held its Senti Biosciences Holdings (SNTI) position steady in Q2 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #2915.

Caitong International Asset Management first reported a position in SNTI in Q1 2026 and has held it in 2 quarters since. 17 funds tracked by Wall St. Rank hold SNTI as of Q2 2026.

  • Caitong International Asset Management held 1 share of Senti Biosciences Holdings worth $1 as of Q2 2026.
  • Caitong International Asset Management left its Senti Biosciences Holdings share count unchanged in Q2 2026.
  • Senti Biosciences Holdings made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2915 holding.
  • Caitong International Asset Management first reported a position in Senti Biosciences Holdings in Q1 2026 and has held it in 2 quarters since.
  • 17 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.